Symproic

Chemical Namenaldemedine
Dosage FormTablet (oral; 0.2 mg)
Drug ClassReceptor antagonists
SystemDigestive
CompanyBioDelivery Sciences International Inc.
Approval Year2017

Indication

  • To treat opioid-induced constipations in adults with chronic non-cancer pain.
Last updated on 3/10/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Symproic (Naldemedine) Prescribing Information 2017BioDelivery Sciences International, Inc., Raleigh, NC